
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease
Kelly Claire Simon, Honglei Chen, Michael A. Schwarzschild, et al.
Neurology (2007) Vol. 69, Iss. 17, pp. 1688-1695
Open Access | Times Cited: 226
Kelly Claire Simon, Honglei Chen, Michael A. Schwarzschild, et al.
Neurology (2007) Vol. 69, Iss. 17, pp. 1688-1695
Open Access | Times Cited: 226
Showing 1-25 of 226 citing articles:
The epidemiology of Parkinson's disease: risk factors and prevention
Alberto Ascherio, Michael A. Schwarzschild
The Lancet Neurology (2016) Vol. 15, Iss. 12, pp. 1257-1272
Closed Access | Times Cited: 1538
Alberto Ascherio, Michael A. Schwarzschild
The Lancet Neurology (2016) Vol. 15, Iss. 12, pp. 1257-1272
Closed Access | Times Cited: 1538
Epidemiology and etiology of Parkinson’s disease: a review of the evidence
Karin Wirdefeldt, Hans‐Olov Adami, Philip Cole, et al.
European Journal of Epidemiology (2011) Vol. 26, Iss. S1, pp. 1-58
Open Access | Times Cited: 1148
Karin Wirdefeldt, Hans‐Olov Adami, Philip Cole, et al.
European Journal of Epidemiology (2011) Vol. 26, Iss. S1, pp. 1-58
Open Access | Times Cited: 1148
Epidemiology of Parkinson's disease
Alexis Elbaz, Laure Carcaillon‐Bentata, Sofiane Kab, et al.
Revue Neurologique (2015) Vol. 172, Iss. 1, pp. 14-26
Closed Access | Times Cited: 362
Alexis Elbaz, Laure Carcaillon‐Bentata, Sofiane Kab, et al.
Revue Neurologique (2015) Vol. 172, Iss. 1, pp. 14-26
Closed Access | Times Cited: 362
Associations Between Conventional Cardiovascular Risk Factors and Risk of Peripheral Artery Disease in Men
Michel M. Joosten, Jennifer K. Pai, Monica L. Bertoia, et al.
JAMA (2012) Vol. 308, Iss. 16, pp. 1660-1660
Open Access | Times Cited: 309
Michel M. Joosten, Jennifer K. Pai, Monica L. Bertoia, et al.
JAMA (2012) Vol. 308, Iss. 16, pp. 1660-1660
Open Access | Times Cited: 309
The Therapeutic Potential of Metformin in Neurodegenerative Diseases
Carola Rotermund, Gerrit Machetanz, Julia C. Fitzgerald
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 251
Carola Rotermund, Gerrit Machetanz, Julia C. Fitzgerald
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 251
Diabetes and Risk of Parkinson’s Disease
Qun Xu, Yikyung Park, Xuemei Huang, et al.
Diabetes Care (2011) Vol. 34, Iss. 4, pp. 910-915
Open Access | Times Cited: 250
Qun Xu, Yikyung Park, Xuemei Huang, et al.
Diabetes Care (2011) Vol. 34, Iss. 4, pp. 910-915
Open Access | Times Cited: 250
Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort
Mark L. Wahlqvist, Meei‐Shyuan Lee, Chih-Cheng Hsu, et al.
Parkinsonism & Related Disorders (2012) Vol. 18, Iss. 6, pp. 753-758
Closed Access | Times Cited: 216
Mark L. Wahlqvist, Meei‐Shyuan Lee, Chih-Cheng Hsu, et al.
Parkinsonism & Related Disorders (2012) Vol. 18, Iss. 6, pp. 753-758
Closed Access | Times Cited: 216
Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification?
Fares Bassil, Pierre‐Olivier Fernagut, Erwan Bézard, et al.
Progress in Neurobiology (2014) Vol. 118, pp. 1-18
Closed Access | Times Cited: 207
Fares Bassil, Pierre‐Olivier Fernagut, Erwan Bézard, et al.
Progress in Neurobiology (2014) Vol. 118, pp. 1-18
Closed Access | Times Cited: 207
The Role of Lipids in Parkinson’s Disease
Helena Xicoy, Bé Wieringa, Gerard J.M. Martens
Cells (2019) Vol. 8, Iss. 1, pp. 27-27
Open Access | Times Cited: 201
Helena Xicoy, Bé Wieringa, Gerard J.M. Martens
Cells (2019) Vol. 8, Iss. 1, pp. 27-27
Open Access | Times Cited: 201
Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease
Irina Alecu, Steffany A. L. Bennett
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 199
Irina Alecu, Steffany A. L. Bennett
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 199
The emerging role of nutrition in Parkinson's disease
Stacey E. Seidl, José A. Santiago, Hope McClusky Bilyk, et al.
Frontiers in Aging Neuroscience (2014) Vol. 6
Open Access | Times Cited: 195
Stacey E. Seidl, José A. Santiago, Hope McClusky Bilyk, et al.
Frontiers in Aging Neuroscience (2014) Vol. 6
Open Access | Times Cited: 195
Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression
Harneek Chohan, Konstantin Senkevich, Radhika K. Patel, et al.
Movement Disorders (2021) Vol. 36, Iss. 6, pp. 1420-1429
Open Access | Times Cited: 158
Harneek Chohan, Konstantin Senkevich, Radhika K. Patel, et al.
Movement Disorders (2021) Vol. 36, Iss. 6, pp. 1420-1429
Open Access | Times Cited: 158
Temporal trends in the prevalence of Parkinson's disease from 1980 to 2023: a systematic review and meta-analysis
Jinqiao Zhu, Yusha Cui, Junjiao Zhang, et al.
The Lancet Healthy Longevity (2024) Vol. 5, Iss. 7, pp. e464-e479
Open Access | Times Cited: 45
Jinqiao Zhu, Yusha Cui, Junjiao Zhang, et al.
The Lancet Healthy Longevity (2024) Vol. 5, Iss. 7, pp. e464-e479
Open Access | Times Cited: 45
Major nutritional issues in the management of Parkinson's disease
Michela Barichella, Emanuele Cereda, Gianni Pezzoli
Movement Disorders (2009) Vol. 24, Iss. 13, pp. 1881-1892
Open Access | Times Cited: 227
Michela Barichella, Emanuele Cereda, Gianni Pezzoli
Movement Disorders (2009) Vol. 24, Iss. 13, pp. 1881-1892
Open Access | Times Cited: 227
Diabetes and Risk of Parkinson’s Disease
Emanuele Cereda, Michela Barichella, Carlo Pedrolli, et al.
Diabetes Care (2011) Vol. 34, Iss. 12, pp. 2614-2623
Open Access | Times Cited: 213
Emanuele Cereda, Michela Barichella, Carlo Pedrolli, et al.
Diabetes Care (2011) Vol. 34, Iss. 12, pp. 2614-2623
Open Access | Times Cited: 213
Total cholesterol and the risk of Parkinson disease
Gang Hu, Riitta Antikaínen, Pekka Jousilahti, et al.
Neurology (2008) Vol. 70, Iss. 21, pp. 1972-1979
Closed Access | Times Cited: 197
Gang Hu, Riitta Antikaínen, Pekka Jousilahti, et al.
Neurology (2008) Vol. 70, Iss. 21, pp. 1972-1979
Closed Access | Times Cited: 197
Diabetes and the Risk of Developing Parkinson’s Disease in Denmark
Eva Schernhammer, Johnni Hansen, Kathrine Rugbjerg, et al.
Diabetes Care (2011) Vol. 34, Iss. 5, pp. 1102-1108
Open Access | Times Cited: 185
Eva Schernhammer, Johnni Hansen, Kathrine Rugbjerg, et al.
Diabetes Care (2011) Vol. 34, Iss. 5, pp. 1102-1108
Open Access | Times Cited: 185
Risk of Parkinson Disease Onset in Patients With Diabetes
Yu Sun, Ya‐Hui Chang, Hua-Fen Chen, et al.
Diabetes Care (2012) Vol. 35, Iss. 5, pp. 1047-1049
Open Access | Times Cited: 171
Yu Sun, Ya‐Hui Chang, Hua-Fen Chen, et al.
Diabetes Care (2012) Vol. 35, Iss. 5, pp. 1047-1049
Open Access | Times Cited: 171
Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's Disease
Jane A. Driver, Ashley Smith, Julie E. Buring, et al.
Diabetes Care (2008) Vol. 31, Iss. 10, pp. 2003-2005
Open Access | Times Cited: 160
Jane A. Driver, Ashley Smith, Julie E. Buring, et al.
Diabetes Care (2008) Vol. 31, Iss. 10, pp. 2003-2005
Open Access | Times Cited: 160
Risk of Parkinson Disease in Diabetes Mellitus
Xuejing Yue, Hehua Li, Haiqing Yan, et al.
Medicine (2016) Vol. 95, Iss. 18, pp. e3549-e3549
Open Access | Times Cited: 155
Xuejing Yue, Hehua Li, Haiqing Yan, et al.
Medicine (2016) Vol. 95, Iss. 18, pp. e3549-e3549
Open Access | Times Cited: 155
Obesity, diabetes, and risk of Parkinson's disease
Natalia Palacios, Xiang Gao, Marjorie L. McCullough, et al.
Movement Disorders (2011) Vol. 26, Iss. 12, pp. 2253-2259
Open Access | Times Cited: 153
Natalia Palacios, Xiang Gao, Marjorie L. McCullough, et al.
Movement Disorders (2011) Vol. 26, Iss. 12, pp. 2253-2259
Open Access | Times Cited: 153
Use of Calcium Channel Blockers and Parkinson’s Disease
Björn Pasternak, Henrik Svanström, Nete Munk Nielsen, et al.
American Journal of Epidemiology (2012) Vol. 175, Iss. 7, pp. 627-635
Open Access | Times Cited: 148
Björn Pasternak, Henrik Svanström, Nete Munk Nielsen, et al.
American Journal of Epidemiology (2012) Vol. 175, Iss. 7, pp. 627-635
Open Access | Times Cited: 148
Clinical features of Parkinson disease when onset of diabetes came first
Emanuele Cereda, Michela Barichella, E. Cassani, et al.
Neurology (2012) Vol. 78, Iss. 19, pp. 1507-1511
Closed Access | Times Cited: 147
Emanuele Cereda, Michela Barichella, E. Cassani, et al.
Neurology (2012) Vol. 78, Iss. 19, pp. 1507-1511
Closed Access | Times Cited: 147
Update in the epidemiology of Parkinson's disease
Alexis Elbaz, Frédéric Moisan
Current Opinion in Neurology (2008) Vol. 21, Iss. 4, pp. 454-460
Closed Access | Times Cited: 141
Alexis Elbaz, Frédéric Moisan
Current Opinion in Neurology (2008) Vol. 21, Iss. 4, pp. 454-460
Closed Access | Times Cited: 141
Dementia is associated with Insulin Resistance in patients with Parkinson's Disease
Domenico Bosco, Massimiliano Plastino, Dario Cristiano, et al.
Journal of the Neurological Sciences (2012) Vol. 315, Iss. 1-2, pp. 39-43
Closed Access | Times Cited: 136
Domenico Bosco, Massimiliano Plastino, Dario Cristiano, et al.
Journal of the Neurological Sciences (2012) Vol. 315, Iss. 1-2, pp. 39-43
Closed Access | Times Cited: 136